This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The University of North Carolina at Chapel Hill, Children's Medical Center Corporation, Clemson University. Active years: 2000-2025.
Location History:
- Hanscom, AFB, US (2000)
- Durham, NC (US) (2002 - 2015)
- Charleston, SC (US) (2022)
- Mount Pleasant, SC (US) (2024)
Company Filing History:
4 out of 1,325 
1 out of 1,072 
1 out of 458 
Years Active: 2000-2025
Title: Nancy Klauber DeMore: Innovator in Antibody Research
Introduction
Nancy Klauber DeMore is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of antibody research, particularly in the development of humanized antibodies targeting SFRP2. With a total of 7 patents, her work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
One of her latest patents focuses on compositions and methods comprising SFRP2 antagonists. This patent provides humanized antibodies and antigen-binding fragments that specifically bind to SFRP2. These compositions can be utilized to treat diseases associated with increased SFRP2 levels, such as cancer and osteosarcoma. The innovative nature of her work lies in the potential therapeutic applications of these antibodies.
Career Highlights
Throughout her career, Nancy has been associated with the University of North Carolina at Chapel Hill, where she has contributed to groundbreaking research. Her expertise in antibody development has positioned her as a key figure in her field.
Collaborations
Nancy has collaborated with notable professionals, including Cam Patterson and Robert J D'Amato. These partnerships have further enhanced her research and innovation in antibody therapies.
Conclusion
Nancy Klauber DeMore's contributions to antibody research exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in the field.